Voyageur Pharmaceuticals Ltd. (OTCMKTS:VYYRF – Get Free Report) saw a large drop in short interest during the month of May. As of May 15th, there was short interest totaling 25 shares, a drop of 99.9% from the April 30th total of 30,720 shares. Based on an average daily volume of 6,568 shares, the short-interest ratio is presently 0.0 days.
Voyageur Pharmaceuticals Stock Performance
Shares of OTCMKTS:VYYRF remained flat at $0.06 during mid-day trading on Wednesday. Voyageur Pharmaceuticals has a one year low of $0.00 and a one year high of $0.24. The stock has a 50 day moving average of $0.09 and a 200 day moving average of $0.10.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals, Inc is a biopharmaceutical company specializing in advanced drug-delivery technologies and contract development services. The company focuses on formulating and optimizing therapeutic compounds to enhance stability, bioavailability and controlled-release properties. By leveraging proprietary polymer- and lipid-based delivery platforms, Voyageur aims to partner with pharmaceutical and biotechnology firms to address formulation challenges in high-value therapeutic areas, including oncology, endocrinology and central nervous system disorders.
The company’s core offerings include formulation development, analytical testing, preclinical evaluation and small-scale manufacturing support.
Featured Articles
- Five stocks we like better than Voyageur Pharmaceuticals
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
